The PKeye Workflow Monitor offers 24/7 monitoring capabilities to ensure high productivity and throughput WALTHAM, Mass. – November 22, 2021 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer... Read more
Program offers practical, routine and reliable SARS-CoV-2 tests to protect New York’s students and communities WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its collaboration with the Mount Sinai Health System to increase accessibility of SARS-CoV-2 testing in New York City. The laboratory system located at the Mount Sinai Beth... Read more
Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment WALTHAM, Mass.–(BUSINESS WIRE)–May 17, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million).... Read more
ONE Pesticide420™ solution delivers enhanced cannabis & hemp testing experience with 70+ ready-to-use certified calibration levels WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched its ONE Pesticide420™ CRM Reagent and Consumable Kit for cannabis & hemp testing. Initially the kits will support pesticide and mycotoxin testing for cannabis &... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the first cell painting kit as part of its new portfolio of PhenoVue™ cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside the Company’s microplates, automation, software and industry-leading... Read more
New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings extend the... Read more
New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings... Read more
PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 WALTHAM, Mass. & LONDON–(BUSINESS WIRE)–Jan. 7, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) (“Oxford Immunotec” or the “Company”) are pleased to announce they have reached an... Read more
Automatable and reliable COVID-19 test rounds out Company’s menu of offerings for acute diagnostics of the virus WALTHAM, Mass. – December 16, 2020 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein. The assay adds to the Company’s broad product... Read more
Solution designed for complex matrices, delivering high sensitivity, single sample prep and high throughput processing WHAT: PerkinElmer , a global leader committed to innovating for a healthier world, today announced its MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits featuring automated Read more